SHUKRA PHARMACEUTICALS
Back to Income Statement
|
SHUKRA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹57 Cr | ₹33 Cr | ₹75 Cr | ₹59 Cr | ₹20 Cr |
What is the latest Revenue of SHUKRA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹57 Cr |
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹59 Cr |
| Mar2022 | ₹20 Cr |
How is Revenue of SHUKRA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹57 Cr | 74.01 | |
| Mar2025 | ₹33 Cr | -56.30 | |
| Mar2024 | ₹75 Cr | 26.75 | |
| Mar2023 | ₹59 Cr | 187.19 | |
| Mar2022 | ₹20 Cr | - | |
Compare Revenue of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹3,194.9 Cr | 20% | 39.4% | 99.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 20% |
39.4% |
99.5% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses